- Home
- / Exact Sciences
Exact Sciences
Stock Price
$69.6
2024-10-29
Market Capitalization
$12.8 B
2024-10-28
Revenue
$3.2 B
FY, 2025
Exact Sciences Summary
Company Summary
- Overview
- Exact Sciences is a company that provides cancer screening and diagnostic test products. It offers DNA-based colorectal cancer screening, genomic, and breast recurrence score test systems, hepatocellular carcinoma (HCC) detection devices, etc.
- Type
- Public
- Status
- Active
- Founded
- 1995
- HQ
- Madison, WI, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Graham Lidgard, CSO, Emeritus
Pat Setji, General Manager, Screening
G. Bradley Cole, General Manager, Precision Oncology
Operating MetricsView all
Testing Services
6
14.3%
FY, 2022
Facility Space, sq. ft.
1.8M
16.4%
FY, 2022
LocationsView all
13 locations detected
Madison, WI HQ
United States
5505 Endeavor Lane
Baltimore, MD
United States
1812 Ashland Avenue Suite 640
Cambridge, MA
United States
222 Jacobs Street, 9th Floor
Phoenix, AZ
United States
445 N. 5th Street
Redwood City, CA
United States
101 Galveston Drive
Salt Lake City, UT
United States
358 S 300 E
Exact Sciences Financials
Summary Financials
- Revenue (FY, 2025)
- $3.2B
- Gross profit (FY, 2025)
- $2.3B
- Net income (FY, 2025)
- ($207.9M)
- Cash (FY, 2025)
- $956.0M
- EBIT (FY, 2025)
- ($206.3M)
- Enterprise value
- $14.4B